title: Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.
abstract: Alterations in the membrane structure and function of hepatocyte membranes by fumonisin B1 (FB1) have been proposed to play an important role in the disruption of growth regulatory effects and hence in the cancer-promoting ability of the mycotoxin. Detailed analyses of lipids in liver microsomal fractions of rats exposed to different dietary levels of FB1 over a period of 21 d indicated an increase in PC, PE, PI, and cholesterol (Chol). These changes decreased the PC/PE and increased the total phospholipid/Chol ratios. When considering FA content, the quantities of total FA increased (P < 0.05) in the major phospholipid fractions as a result of the increased phospholipid levels. However, when considering the relative levels (mg/100 mg of the total FA) of specific FA, the monounsaturated FA (16:1 n-7 and 18:1n-9) and 18:2n-6 increased (P < 0.05), whereas the long-chain PUFA decreased (P < 0.05) in the main phospholipid fractions. Enzyme analyses indicated that the activity of the delta6-desaturase was significantly reduced in liver microsomal preparations in a dose-dependent manner. An increase in the 20:3n-6/20:4n-6 ratio also suggested a decrease in the activity of the delta5-desaturase. Disruption of microsomal lipid metabolism at different levels by FB1 could play an important role in the alteration of growth regulatory effects in the liver.
authors.affiliation: PROMEC Unit, Medical Research Council, Tygerberg 7505, South Africa. wentzel.gelderblom@mrc.ac.za
authors.forename: W C A
authors.initials: WC
authors.lastname: Gelderblom
authors.forename: W
authors.initials: W
authors.lastname: Moritz
authors.forename: S
authors.initials: S
authors.lastname: Swanevelder
authors.forename: C M
authors.initials: CM
authors.lastname: Smuts
authors.forename: S
authors.initials: S
authors.lastname: Abel
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004305:Dose-Response Relationship, Drug; D044943:Fatty Acid Desaturases / Q000378:metabolism*; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism; D037341:Fumonisins / Q000008:administration & dosage / Q000494:pharmacology*; D007425:Intracellular Membranes / Q000187:drug effects* / Q000378:metabolism*; D050602:Linoleoyl-CoA Desaturase; D050356:Lipid Metabolism; D008055:Lipids / Q000737:chemistry; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008862:Microsomes, Liver / Q000187:drug effects*; D010743:Phospholipids / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D051381:Rats
chemical_list: D005227:Fatty Acids; D037341:Fumonisins; D008055:Lipids; D010743:Phospholipids; C056933:fumonisin B1; D044943:Fatty Acid Desaturases; D050602:Linoleoyl-CoA Desaturase